CTD402

· BIOHENG THERAPEUTICS US LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTD402, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CTD402 in T-ALL/LBL Patients [Phase 1, Phase 2]